XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 8,671,099 $ 213,944
Accounts receivable 128,600 41,000
Deferred offering costs 135,608
Deferred expenses 13,988 35,153
Other current assets 139,651 118,020
Total current assets 8,953,338 543,725
Property and equipment, net 3,570
Intangible assets, net 67,689  
Other assets 90,000 90,000
Total assets 9,114,597 633,725
Current liabilities:    
Accounts payable 784,538 1,355,064
Accrued liabilities 404,340 119,226
Deferred revenue 44,602 47,718
Related party advances 9,629 9,629
Note payable, net of discount 46,368
Notes payable - related party, net of discount 278,607
Settlement payable 24,444
Total current liabilities 1,243,109 1,881,056
Total liabilities 1,243,109 1,881,056
Commitments and contingencies (Note 3)
Stockholders' equity (deficit):    
Preferred stock, 15,000,000 shares authorized, par value $0.00001, 0 and 2,429,638 issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 1,591,886
Common stock, 50,000,000 share authorized, par value $0.00001, 11,708,041 and 5,252,953 issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 117 52
Additional paid-in capital 21,728,618 2,553,672
Subscription receivable - related party (7,392) (140,087)
Accumulated deficit (13,849,855) (5,252,854)
Total stockholders' equity (deficit) 7,871,488 (1,247,331)
Total liabilities and stockholders' equity (deficit) $ 9,114,597 $ 633,725